Research NewsGenomics

Drug Firms Back Move to Link Databases

Science  15 Aug 1997:
Vol. 277, Issue 5328, pp. 902
DOI: 10.1126/science.277.5328.902b

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

A group of leading pharmaceutical companies last week put their considerable weight behind the development of common standards for the interface between biological databases, based on an approach popular in the computer industry. But bioinformatics specialists who run some key databases used by academic researchers say they are not enamored of the interface standards chosen, although they may now be forced to adopt them.

Related Content